(Q45216680)
English
A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with p
scientific article published in November 2004
Statements
1 reference
A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with p (English)
1 reference
Harold E Bays
1 reference
Leiv Ose
1 reference
Neil Fraser
1 reference
Diane L Tribble
1 reference
Katherine Quinto
1 reference
Robert Reyes
1 reference
Amy O Johnson-Levonas
1 reference
Aditi Sapre
1 reference
Steven R Donahue
1 reference
Ezetimibe Study Group
1 reference
1 November 2004
1 reference
1 reference
Identifiers
1 reference